US equities |
MU $1,045.56 ▲+0.00% INTC $112.50 ▲+0.00% NVDA $239.24 ▲+0.00% SNDK $1,660.46 ▲+0.00% SPCX $171.92 ▲+0.00% MRVL $287.01 ▲+0.00% AMD $649.42 ▲+0.00% MSTR $164.55 ▲+0.00%
FinancialContent

Damora Therapeutics, Inc. - Ordinary Shares (NQ:DMRA)

19.55 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Damora Therapeutics, Inc. - Ordinary Shares

News headline image
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Damora Therapeutics, Inc.
Via GlobeNewswire
News headline image
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Damora Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge ↗
This clinical-stage biotech develops small molecule therapies for cancer and fibrotic diseases, focusing on galectin-3 and LOXL2 inhibitors. 
Via The Motley Fool